Company Filing History:
Years Active: 2001-2002
Title: Innovations by Long-Shiuh Chen in Sickle Cell Anemia Treatment
Introduction
Long-Shiuh Chen is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of medicine, particularly in the treatment of sickle cell anemia. With a total of two patents to his name, Chen's work focuses on improving therapeutic methods for this challenging condition.
Latest Patents
Chen's latest patents revolve around methods for the treatment of sickle cell anemia. He describes the preparation and use of a protected organic aldehyde that enhances the bioavailability of orally administered therapeutic aldehydes. This innovation involves chemically condensing the aldehyde with a protecting group, such as thiazolidine-4-carboxylic acid. The improved bioavailability of these drugs increases the feasibility of delivering sufficient amounts of vanillin or other therapeutic organic aldehydes in vivo, which can help prevent sickling in patients with sickle cell anemia. Additionally, he explores combination therapy, where a protected organic aldehyde is administered alongside other drugs, such as painkillers, to treat the symptoms of sickle cell anemia or sickle cell disease.
Career Highlights
Long-Shiuh Chen is currently associated with Medinox, Inc., where he continues to innovate in the field of medical treatments. His work has the potential to significantly impact the lives of those suffering from sickle cell anemia.
Collaborations
Chen collaborates with notable colleagues, including Ching-San Lai and Vassil P Vassilev, who contribute to his research and development efforts.
Conclusion
Long-Shiuh Chen's innovative approaches to treating sickle cell anemia highlight his dedication to improving patient outcomes through scientific advancements. His patents reflect a commitment to enhancing the effectiveness of therapeutic treatments in this critical area of healthcare.